Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  adenosine A2A receptor antagonist PBF-509
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC18321, NCI-2015-01728, PBFCC07, NCT02403193
Start Over